tomeko

Spinal muscular atrophy with lower extremity predominance

Just diagnosed with Spinal muscular atrophy with lower extremity predominance?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Spinal muscular atrophy with lower extremity predominance, look for clinical trials, and connect with others living with it — all in one place.

Open the full Spinal muscular atrophy with lower extremity predominance hub →

Overview

Spinal muscular atrophy with lower extremity predominance is a rare condition. Also known as Lower extremity-predominant autosomal dominant proximal spinal muscular atrophy, SMALED. Tomeko brings together the specialists, research, clinical trials, treatments and community for Spinal muscular atrophy with lower extremity predominance so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:363447 · OMIM 158600, 615290 · ICD-10 G12.1 · GARD 0017559

Find care for Spinal muscular atrophy with lower extremity predominance

Authoritative references for Spinal muscular atrophy with lower extremity predominance

Common questions

I was just diagnosed with Spinal muscular atrophy with lower extremity predominance — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Spinal muscular atrophy with lower extremity predominance, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Spinal muscular atrophy with lower extremity predominance?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Spinal muscular atrophy with lower extremity predominance, filtered to your area.

Are there clinical trials for Spinal muscular atrophy with lower extremity predominance?

Tomeko shows live, recruiting studies for Spinal muscular atrophy with lower extremity predominance from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com